{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:45:42Z","timestamp":1791193542146,"version":"4.1.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,8,1]],"date-time":"2012-08-01T00:00:00Z","timestamp":1343779200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhltonline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Heart and Lung Transplantation"],"published-print":{"date-parts":[[2012,8]]},"DOI":"10.1016\/j.healun.2012.03.008","type":"journal-article","created":{"date-parts":[[2012,5,2]],"date-time":"2012-05-02T12:11:39Z","timestamp":1335960699000},"page":"797-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":110,"title":["Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation"],"prefix":"10.1016","volume":"31","author":[{"given":"Hendrik","family":"Treede","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan R.","family":"Glanville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Klepetko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Aboyoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eik","family":"Vettorazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffael","family":"Lama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Bravo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John-David","family":"Aubert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Reichenspurner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.healun.2012.03.008_bib1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.healun.2010.08.004","article-title":"The registry of the International Society for Heart and Lung Transplantation: twenty-seventh official adult lung and heart\u2013lung transplantation report\u20142010","volume":"29","author":"Christie","year":"2010","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.healun.2007.01.040","article-title":"Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation","volume":"26","author":"Snell","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S1053-2498(02)00398-4","article-title":"Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria","volume":"21","author":"Estenne","year":"2002","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib4","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1056\/NEJM198605013141802","article-title":"Unilateral lung transplantation for pulmonary fibrosis","volume":"314","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2012.03.008_bib5","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1056\/NEJM199410273311702","article-title":"A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression in liver transplantation","volume":"331","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/j.healun.2012.03.008_bib6","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.healun.2007.07.027","article-title":"A randomized controlled trial of tacrolimus versus cyclosporine after lung transplantation","volume":"26","author":"Hachem","year":"2007","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib7","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/0003-4975(95)00407-C","article-title":"Clinical trial of tacrolimus versus cyclosporine in lung transplantation","volume":"60","author":"Keenan","year":"1995","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/j.healun.2012.03.008_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S1053-2498(01)00244-3","article-title":"Tacrolimus versus cyclosporine after lung transplantation: a prospective, open, randomized two-center trial comparing two different immunosuppressive protocols","volume":"20","author":"Treede","year":"2001","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib9","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1067\/mtc.2003.71","article-title":"Cyclosporine A versus tacrolimus in combination with mycophenolate mofetil and steroids as primary immunosuppression after lung transplantation: one-year results of a 2-center prospective randomized trial","volume":"125","author":"Zuckermann","year":"2003","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.healun.2012.03.008_bib10","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.jtcvs.2003.11.009","article-title":"International experience with conversion from cyclosporine to tacrolimus for acute and chronic lung allograft rejection","volume":"127","author":"Sarahrudi","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"suppl 2","key":"10.1016\/j.healun.2012.03.008_bib11","first-page":"1","article-title":"Inhibition of human T-cell activation by FK 506, rapamycin, and cyclosporine A","volume":"23","author":"Sigal","year":"1991","journal-title":"Transplant Proc"},{"key":"10.1016\/j.healun.2012.03.008_bib12","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S1053-2498(02)00548-X","article-title":"Time-related changes in pulmonary function after conversion to tacrolimus in bronchiolitis obliterans syndrome","volume":"22","author":"Cairn","year":"2003","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib13","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1097\/01.tp.0000202755.33883.61","article-title":"Comparison of mycophenolate mofetil and azathioprine for prevention of bronchiolitis obliterans syndrome in de novo lung transplant recipients","volume":"81","author":"McNeil","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2012.03.008_bib14","first-page":"768","article-title":"Mycophenolate mofetil versus azathioprine immunosuppressive regimens after lung transplantation: preliminary experience","volume":"17","author":"Ross","year":"1998","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/S1053-2498(99)00004-2","article-title":"Comparison between mycophenolate mofetil- and azathioprine-based immunosuppressions in clinical lung transplantation","volume":"18","author":"Zuckermann","year":"1999","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib16","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.healun.2012.03.008_bib17","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00007890-199604150-00008","article-title":"A blinded, randomized clinical trial of mycophenolate mofetil for the prevention of acute rejection in cadaveric renal transplantation","volume":"61","year":"1996","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2012.03.008_bib18","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","article-title":"A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients","volume":"66","author":"Kobashigawa","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2012.03.008_bib19","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.healun.2006.03.020","article-title":"Cyclosporine C2 target levels and acute cellular rejection after lung transplantation","volume":"25","author":"Glanville","year":"2006","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib20","doi-asserted-by":"crossref","first-page":"c332","DOI":"10.1136\/bmj.c332","article-title":"CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials","volume":"340","author":"Schulz","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/j.healun.2012.03.008_bib21","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/S1053-2498(00)00138-8","article-title":"The registry of the International Society for Heart and Lung Transplantation: seventeenth official report\u20142000","volume":"19","author":"Hosenpud","year":"2000","journal-title":"J Heart Lung Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib22","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1097\/00007890-200206150-00019","article-title":"Tacrolimus and cyclosporine differ in their capacity to overcome ongoing allograft rejection as a result of their differential abilities to inhibit interleukin-10 production","volume":"73","author":"Jiang","year":"2002","journal-title":"Transplantation"},{"key":"10.1016\/j.healun.2012.03.008_bib23","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1097\/00007890-199902270-00021","article-title":"Tacrolimus induces increased expression of transforming growth factor-beta1 in mammalian lymphoid as well as nonlymphoid cells","volume":"67","author":"Khanna","year":"1999","journal-title":"Transplantation"},{"issue":"suppl 3","key":"10.1016\/j.healun.2012.03.008_bib24","first-page":"159","article-title":"Long-term follow-up of a prospective randomized trial of tacrolimus versus cyclosporine in human lung transplantation","volume":"2","author":"McCurry","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1016\/j.healun.2012.03.008_bib25","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1164\/rccm.200706-951OC","article-title":"Severity of lymphocytic bronchiolitis predicts long-term outcome after lung transplantation","volume":"177","author":"Glanville","year":"2008","journal-title":"Am J Respir Crit Care Med"}],"container-title":["The Journal of Heart and Lung Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249812010418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1053249812010418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T08:24:23Z","timestamp":1760948663000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1053249812010418"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,8]]},"references-count":25,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2012,8]]}},"alternative-id":["S1053249812010418"],"URL":"https:\/\/doi.org\/10.1016\/j.healun.2012.03.008","relation":{},"ISSN":["1053-2498"],"issn-type":[{"value":"1053-2498","type":"print"}],"subject":[],"published":{"date-parts":[[2012,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tacrolimus and cyclosporine have differential effects on the risk of development of bronchiolitis obliterans syndrome: Results of a prospective, randomized international trial in lung transplantation","name":"articletitle","label":"Article Title"},{"value":"The Journal of Heart and Lung Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.healun.2012.03.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society for Heart and Lung Transplantation. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}